Cholesterol Treatment Trialists' (CTT) Collaboration; Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681.
Rhabdomyolysis with HMGCoA reductase inhibitors and gemfi brozil combination therapy
Chang JT, Staff a JA, Parks M, Green L. Rhabdomyolysis with HMGCoA reductase inhibitors and gemfi brozil combination therapy. Pharmacoepidemiol Drug Saf 2004; 13: 417-426.
Meta-analysis of impact of diff erent types and doses of statins on new-onset diabetes mellitus
Navarese EP, Buffon A, Andreotti F, et al. Meta-analysis of impact of diff erent types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 2013; 111: 1123-1130.
National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk, (accessed Apr 2104)
National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2012. http://strokefoundation.com.au/site/media/AbsoluteCVD_GL_webready.pdf (accessed Apr 2104).
(2012)
7
84904866464
National Heart Foundation of Australia. Clinical information. Lipid management, (accessed Apr
National Heart Foundation of Australia. Clinical information. Lipid management. http://www.heartfoundation.org.au/information-forprofessionals/ Clinical-Information/Pages/lipid-management.aspx (accessed Apr 2014).
(2014)
8
84904896503
National Heart Foundation of Australia. Secondary prevention of cardiovascular disease, (accessed Apr 2014)
National Heart Foundation of Australia. Secondary prevention of cardiovascular disease. 2010. http://www.heartfoundation.org.au/ SiteCollectionDocuments/Secondary-Prevention-of-cardiovasculardisease.pdf (accessed Apr 2014).
(2010)
9
84902576469
ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults
A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013; 7 Nov [Epub ahead of print]. doi: 10.1016/j.jacc.2013.11.002
Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 7 Nov [Epub ahead of print]. doi: 10.1016/j.jacc.2013.11.002.
Australian Government Department of Health. PBS expenditure and prescriptions twelve months to 30 June, (accessed Apr 2014)
Australian Government Department of Health. PBS expenditure and prescriptions twelve months to 30 June 2011. http://www.pbs.gov.au/info/ statistics/expenditure-and-prescriptions-30-06-2011 (accessed Apr 2014).
(2011)
11
77957909658
Coronary risk stratifi cation, discrimination, and reclassifi cation improvement based on quantifi cation of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study
Erbel R, Möhlenkamp S, Moebus S, et al. Coronary risk stratifi cation, discrimination, and reclassifi cation improvement based on quantifi cation of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56: 1397-1406.
